Tag: Cardionovum
Late-breaking Xlimit randomised trial data shared at CSC 2022 congress
Data presented at an innovation session at the 2022 Structural and Coronary Intervention Course (CS...
First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD
Cardionovum has announced the enrolment of the first patient in the international Hyper II clini...
TCT 2018: Restore drug-coated balloon matches Resolute for small vessel lesions
Data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 Septem...
